Financhill
Sell
33

COR Quote, Financials, Valuation and Earnings

Last price:
$335.70
Seasonality move :
3.52%
Day range:
$333.79 - $339.47
52-week range:
$233.61 - $377.54
Dividend yield:
0.67%
P/E ratio:
42.22x
P/S ratio:
0.20x
P/B ratio:
43.18x
Volume:
917K
Avg. volume:
1.4M
1-year change:
41.15%
Market cap:
$65.1B
Revenue:
$321.3B
EPS (TTM):
$7.95

Analysts' Opinion

  • Consensus Rating
    Cencora, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $387.93, Cencora, Inc. has an estimated upside of 15.56% from its current price of $335.69.
  • Price Target Downside
    According to analysts, the lowest downside price target is $315.00 representing 6.16% downside risk from its current price of $335.69.

Fair Value

  • According to the consensus of 15 analysts, Cencora, Inc. has 15.56% upside to fair value with a price target of $387.93 per share.

COR vs. S&P 500

  • Over the past 5 trading days, Cencora, Inc. has underperformed the S&P 500 by -2.47% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cencora, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cencora, Inc. has grown year-over-year revenues for 52 quarters straight. In the most recent quarter Cencora, Inc. reported revenues of $83.7B.

Earnings Growth

  • Cencora, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cencora, Inc. reported earnings per share of -$1.75.
Enterprise value:
70.3B
EV / Invested capital:
--
Price / LTM sales:
0.20x
EV / EBIT:
19.27x
EV / Revenue:
0.22x
PEG ratio (5yr expected):
7.10x
EV / Free cash flow:
21.92x
Price / Operating cash flow:
20.40x
Enterprise value / EBITDA:
14.94x
Gross Profit (TTM):
$10.1B
Return On Assets:
2.19%
Net Income Margin (TTM):
0.49%
Return On Equity:
124.72%
Return On Invested Capital:
17.24%
Operating Margin:
1.02%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $262.2B $294B $321.3B $79.1B $83.7B
Gross Profit $7.8B $8.7B $10.1B $2.2B $2.6B
Operating Income $2.4B $3B $3.6B $672.9M $854.6M
EBITDA $3.4B $4.1B $4.7B $951M $1.1B
Diluted EPS $8.53 $7.51 $7.95 $0.02 -$1.75
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $38.8B $39.6B $42.8B $47.7B $52.2B
Total Assets $57.3B $56.6B $62.6B $67.1B $76.6B
Current Liabilities $41.4B $43.5B $48.8B $54.3B $57.8B
Total Liabilities $56.8B $56.5B $61.9B $66.3B $74.8B
Total Equity $584.4M $71.3M $666.3M $786.7M $1.7B
Total Debt $7.6B $5.7B $5.7B $5.4B $9.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $3.9B $3.5B $3.9B $1B $3.1B
Cash From Investing -$2.6B -$618.1M -$5B -$241.9M -$321.9M
Cash From Financing -$2.2B -$2.3B $2.2B -$957.3M -$683.8M
Free Cash Flow $3.5B $3B $3.2B $818.1M $2.9B
COR
Sector
Market Cap
$65.1B
$28.1M
Price % of 52-Week High
88.92%
51.87%
Dividend Yield
0.67%
0%
Shareholder Yield
-0.14%
-1.59%
1-Year Price Total Return
41.15%
-17.31%
Beta (5-Year)
0.664
0.495
Dividend yield:
0.67%
Annualized payout:
$2.20
Payout ratio:
15.62%
Growth streak:
20 years

Technicals

8-day SMA
Sell
Level $339.45
200-day SMA
Buy
Level $308.24
Bollinger Bands (100)
Buy
Level 302.2 - 352.8
Chaikin Money Flow
Buy
Level 471.9M
20-day SMA
Sell
Level $341.23
Relative Strength Index (RSI14)
Sell
Level 40.86
ADX Line
Sell
Level 13.19
Williams %R
Neutral
Level -67.7751
50-day SMA
Sell
Level $349.13
MACD (12, 26)
Sell
Level -2.31
25-day Aroon Oscillator
Sell
Level -52
On Balance Volume
Neutral
Level 185.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.8706)
Sell
CA Score (Annual)
Level (-0.7035)
Buy
Beneish M-Score (Annual)
Level (-2.5377)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.8039)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Stock Forecast FAQ

In the current month, COR has received 10 Buy ratings 5 Hold ratings, and 0 Sell ratings. The COR average analyst price target in the past 3 months is $387.93.

  • Where Will Cencora, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cencora, Inc. share price will rise to $387.93 per share over the next 12 months.

  • What Do Analysts Say About Cencora, Inc.?

    Analysts are divided on their view about Cencora, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cencora, Inc. is a Sell and believe this share price will drop from its current level to $315.00.

  • What Is Cencora, Inc.'s Price Target?

    The price target for Cencora, Inc. over the next 1-year time period is forecast to be $387.93 according to 15 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is COR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cencora, Inc. is a Buy. 10 of 15 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of COR?

    You can purchase shares of Cencora, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cencora, Inc. shares.

  • What Is The Cencora, Inc. Share Price Today?

    Cencora, Inc. was last trading at $335.70 per share. This represents the most recent stock quote for Cencora, Inc.. Yesterday, Cencora, Inc. closed at $335.69 per share.

  • How To Buy Cencora, Inc. Stock Online?

    In order to purchase Cencora, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock